Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
In Asia Pacific, Amgen, headquartered in Hong Kong, has an R&D Center in Shanghai, biotech manufacturing facility in Singapore and country offices across the region. Amgen's expansion in the region comes at a time when the region's healthcare needs continue to grow particularly around serious diseases as the region becomes one of the fastest aging population.
Learn more about Amgen Hong Kong: www.amgen.hk/